XOMAP
Price:
$24.98
Market Cap:
$503.77M
XOMA Royalty Corporation operates as a biotech royalty aggregator in the United States, Switzerland, the Asia Pacific, and Australia. It has a portfolio of economic rights to future potential milestone and royalty payments associated with commercial products and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to sponsors or developers; and acquires milestone and royalty revenue streams on late-stage clinical assets and commercial assets. It has a portfolio with various assets. The company was formerly known as XOMA Corporation and changed its name to XOMA Royalty...[Read more]
Industry
Biotechnology
IPO Date
2020-12-16
Stock Exchange
NASDAQ
Ticker
XOMAP
According to XOMA Royalty Corporation’s latest financial reports and current stock price. The company's current ROE is 30.21%. This represents a change of 298.84% compared to the average of 7.57% of the last 4 quarters.
The mean historical ROE of XOMA Royalty Corporation over the last ten years is 27.05%. The current 30.21% ROE has changed 11.68% with respect to the historical average. Over the past ten years (40 quarters), XOMAP's ROE was at its highest in in the September 2017 quarter at 648.39%. The ROE was at its lowest in in the September 2018 quarter at -397.05%.
Average
27.05%
Median
3.31%
Minimum
-71.03%
Maximum
252.26%
Discovering the peaks and valleys of XOMA Royalty Corporation ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 233.68%
Maximum Annual ROE = 252.26%
Minimum Annual Increase = -441.49%
Minimum Annual ROE = -71.03%
| Year | ROE | Change |
|---|---|---|
| 2025 | 30.50% | -280.81% |
| 2024 | -16.87% | -63.34% |
| 2023 | -46.02% | 233.68% |
| 2022 | -13.79% | -223.86% |
| 2021 | 11.14% | -27.63% |
| 2020 | 15.39% | -441.49% |
| 2019 | -4.51% | -93.66% |
| 2018 | -71.03% | -128.16% |
| 2017 | 252.26% | 122.48% |
| 2016 | 113.39% | -87.29% |
The current ROE of XOMA Royalty Corporation (XOMAP) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-10.80%
5-year avg
-7.01%
10-year avg
27.05%
XOMA Royalty Corporation’s ROE is greater than Tectonic Therapeutic, Inc. (-35.26%), greater than Aldeyra The (-53.14%), greater than Amarin Corporation plc (-5.99%), greater than AC Immune S.A. (-99.17%), greater than Lyell Immunopharma, Inc. (-91.62%), greater than Genelux Corporation (-195.42%), greater than Silence Therapeutics plc (-106.94%), greater than Cellectis S.A. (-94.14%), greater than Larimar Therapeutics, Inc. (-137.39%), greater than Kyverna Therapeutics, Inc. (-81.91%),
| Company | ROE | Market cap |
|---|---|---|
| -35.26% | $499.56M | |
| -53.14% | $81.43M | |
| -5.99% | $277.15M | |
| -99.17% | $266.14M | |
| -91.62% | $262.32M | |
| -195.42% | $113.89M | |
| -106.94% | $580.98M | |
| -94.14% | $153.64M | |
| -137.39% | $396.72M | |
| -81.91% | $430.76M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XOMA Royalty Corporation using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like XOMA Royalty Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is XOMA Royalty Corporation's ROE?
How is the ROE calculated for XOMA Royalty Corporation (XOMAP)?
What is the highest ROE for XOMA Royalty Corporation (XOMAP)?
What is the 3-year average ROE for XOMA Royalty Corporation (XOMAP)?
What is the 5-year average ROE for XOMA Royalty Corporation (XOMAP)?
How does the current ROE for XOMA Royalty Corporation (XOMAP) compare to its historical average?